”We haven’t noticed any price pressure”
GN Resound has presented good numbers for the first quarter with Anders Hedegaard at the helm, especially due to a better performance on the US market than what its rivals could muster. Now, it is time to defend the lead.
BY STEFAN SINGH KAILAY
It was a more than satisfied Anders Hedegaard MedWatch spoke to following the publication of GN Resound’s first quarterly report with the former Bavarian Nordic chief at the helm – a report whioch – unlike that of homegrown rival William Demant – showed a positive development on the US market.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
WD chief expects no short term change
For abonnenter
Siemens sells hearing devices unit to EQT
For abonnenter
GN walks away from "transforming" acquisition
For abonnenter
